Search research articles
Contact Us
Filters
Showing results (1-10 of 67) with videos related to
Page
of 7
Sort By:
Oncology and Therapy
|
March 7, 2017
Network Meta-analysis of Progression-Free Survival and Overall Survival in First-Line Treatment of BRAF Mutation-Positive Metastatic Melanoma
Jordan Amdahl, Lei Chen, Thomas E Delea
Clinical Therapeutics
|
February 13, 2017
Cost-effectiveness of Pazopanib Versus Sunitinib as First-line Treatment for Locally Advanced or Metastatic Renal Cell Carcinoma from an Italian National Health Service Perspective
Stefano Capri, Camillo Porta, Thomas E Delea
Journal of Medical Economics
|
February 6, 2014
Healthcare costs associated with skeletal-related events in breast cancer patients with bone metastases
May Hagiwara, Thomas E Delea, Karen Chung
Current Medical Research and Opinion
|
August 25, 2010
Cost effectiveness of letrozole versus anastrozole in postmenopausal women with HR+ early-stage breast cancer
Michael Lipsitz, Thomas E Delea, Amy Guo
CNS Drugs
|
December 7, 2010
The association between adherence to levodopa/carbidopa/entacapone therapy and healthcare utilization and costs among patients with Parkinson's disease: a retrospective claims-based analysis
Thomas E Delea, Simu K Thomas, May Hagiwara
The Journal of Asthma : Official Journal of the Association for the Care of Asthma
|
July 29, 2011
Retrospective comparison of early versus late treatment with fluticasone propionate/salmeterol after an asthma exacerbation
May Hagiwara, Thomas E Delea, Richard H Stanford
The Journal of Asthma : Official Journal of the Association for the Care of Asthma
|
January 12, 2013
Risk of asthma exacerbation, asthma-related health care utilization and costs, and adherence to controller therapy in patients with asthma receiving fluticasone propionate/salmeterol inhalation powder 100 μg/50 μg versus mometasone furoate inhalation powder
May Hagiwara, Thomas E Delea, Richard H Stanford
The Journal of Pharmacy Technology : Jpt : Official Publication of the Association of Pharmacy Technicians
|
December 3, 2021
Retrospective Study of the Prevalence, Predictors, and Consequences of Nonadherence With Lapatinib in Women With Metastatic Breast Cancer Who Were Previously Treated With Trastuzumab
Thomas E Delea, Alex Kartashov, Puza P Sharma
Allergy and Asthma Proceedings
|
January 18, 2014
Health-care utilization and costs with fluticasone propionate and fluticasone propionate/salmeterol in asthma patients at risk for exacerbations
May Hagiwara, Thomas E Delea, Richard H Stanford
Current Medical Research and Opinion
|
February 13, 2009
Retrospective study of the association between transfusion frequency and potential complications of iron overload in patients with myelodysplastic syndrome and other acquired hematopoietic disorders
Thomas E Delea, May Hagiwara, Pradyumna D Phatak
Page
of 7
Search research articles
Search
Showing results (1-10 of 67) with videos related to
Sort By:
Page
of 7
Oncology and Therapy
|
March 7, 2017
Network Meta-analysis of Progression-Free Survival and Overall Survival in First-Line Treatment of BRAF Mutation-Positive Metastatic Melanoma
Jordan Amdahl, Lei Chen, Thomas E Delea
Clinical Therapeutics
|
February 13, 2017
Cost-effectiveness of Pazopanib Versus Sunitinib as First-line Treatment for Locally Advanced or Metastatic Renal Cell Carcinoma from an Italian National Health Service Perspective
Stefano Capri, Camillo Porta, Thomas E Delea
Journal of Medical Economics
|
February 6, 2014
Healthcare costs associated with skeletal-related events in breast cancer patients with bone metastases
May Hagiwara, Thomas E Delea, Karen Chung
Current Medical Research and Opinion
|
August 25, 2010
Cost effectiveness of letrozole versus anastrozole in postmenopausal women with HR+ early-stage breast cancer
Michael Lipsitz, Thomas E Delea, Amy Guo
CNS Drugs
|
December 7, 2010
The association between adherence to levodopa/carbidopa/entacapone therapy and healthcare utilization and costs among patients with Parkinson's disease: a retrospective claims-based analysis
Thomas E Delea, Simu K Thomas, May Hagiwara
The Journal of Asthma : Official Journal of the Association for the Care of Asthma
|
July 29, 2011
Retrospective comparison of early versus late treatment with fluticasone propionate/salmeterol after an asthma exacerbation
May Hagiwara, Thomas E Delea, Richard H Stanford
The Journal of Asthma : Official Journal of the Association for the Care of Asthma
|
January 12, 2013
Risk of asthma exacerbation, asthma-related health care utilization and costs, and adherence to controller therapy in patients with asthma receiving fluticasone propionate/salmeterol inhalation powder 100 μg/50 μg versus mometasone furoate inhalation powder
May Hagiwara, Thomas E Delea, Richard H Stanford
The Journal of Pharmacy Technology : Jpt : Official Publication of the Association of Pharmacy Technicians
|
December 3, 2021
Retrospective Study of the Prevalence, Predictors, and Consequences of Nonadherence With Lapatinib in Women With Metastatic Breast Cancer Who Were Previously Treated With Trastuzumab
Thomas E Delea, Alex Kartashov, Puza P Sharma
Allergy and Asthma Proceedings
|
January 18, 2014
Health-care utilization and costs with fluticasone propionate and fluticasone propionate/salmeterol in asthma patients at risk for exacerbations
May Hagiwara, Thomas E Delea, Richard H Stanford
Current Medical Research and Opinion
|
February 13, 2009
Retrospective study of the association between transfusion frequency and potential complications of iron overload in patients with myelodysplastic syndrome and other acquired hematopoietic disorders
Thomas E Delea, May Hagiwara, Pradyumna D Phatak
Page
of 7